These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 28682102)
21. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755 [TBL] [Abstract][Full Text] [Related]
22. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model. Cherniakov I; Izgelov D; Domb AJ; Hoffman A Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128 [TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858 [TBL] [Abstract][Full Text] [Related]
24. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats. Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926 [TBL] [Abstract][Full Text] [Related]
25. Effects of oral Δ9-tetrahydrocannabinol and cannabidiol combinations on a sustained attention task in rats. Moore CF; Davis CM; Sempio C; Klawitter J; Christians U; Weerts EM Exp Clin Psychopharmacol; 2023 Oct; 31(5):881-887. PubMed ID: 36634015 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC. Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557 [TBL] [Abstract][Full Text] [Related]
27. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats. Taffe MA; Creehan KM; Vandewater SA Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111 [TBL] [Abstract][Full Text] [Related]
28. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model. Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405 [TBL] [Abstract][Full Text] [Related]
29. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. Arnold JC; Boucher AA; Karl T Curr Pharm Des; 2012; 18(32):5113-30. PubMed ID: 22716133 [TBL] [Abstract][Full Text] [Related]
30. Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats. Zuardi AW; Teixeira NA; Karniol IC Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750 [TBL] [Abstract][Full Text] [Related]
33. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats. Malone DT; Jongejan D; Taylor DA Pharmacol Biochem Behav; 2009 Aug; 93(2):91-6. PubMed ID: 19393686 [TBL] [Abstract][Full Text] [Related]
34. Female but not male rats show biphasic effects of low doses of Δ Salviato BZ; Raymundi AM; Rodrigues da Silva T; Salemme BW; Batista Sohn JM; Araújo FS; Guimarães FS; Bertoglio LJ; Stern CA Neuropharmacology; 2021 Sep; 196():108684. PubMed ID: 34181978 [TBL] [Abstract][Full Text] [Related]
36. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990 [TBL] [Abstract][Full Text] [Related]
37. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Murphy LL; Steger RW; Smith MS; Bartke A Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838 [TBL] [Abstract][Full Text] [Related]
38. Behavioral Effects of Vaporized Delta-8 Tetrahydrocannabinol, Cannabidiol, and Mixtures in Male Rats. Durbin DJ; King JM; Stairs DJ Cannabis Cannabinoid Res; 2024 Apr; 9(2):601-611. PubMed ID: 36802211 [No Abstract] [Full Text] [Related]
39. Cannabidiol Interferes with Establishment of Δ DeVuono MV; La Caprara O; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA Cannabis Cannabinoid Res; 2022 Feb; 7(1):58-64. PubMed ID: 33998876 [No Abstract] [Full Text] [Related]
40. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol. Hollister LE; Gillespie H Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]